Zeal Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Zeal Asset Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-194,538	Closed	-$2.06M	–	7
2022 Q2	$2.06M	Hold	194,538	–	–	4.25%	5
2022 Q1	$3.25M	Sell	194,538 -1,190,286	-86%	-$30.5M	4.23%	5
2021 Q4	$67.6M	Sell	1,384,824 -316,441	-19%	-$19M	40.66%	2
2021 Q3	$125M	Buy	1,701,265 +713,414	+72%	+$51.6M	37.52%	1
2021 Q2	$83.7M	Buy	+987,851	New	+$65.2M	19.08%	3

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Zeal Asset Management's NBP Position: Q3 2022 in Review

Zeal Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 194,538 shares — an estimated $2.06M sold.

Zeal Asset Management first reported a position in NBP in Q2 2021 and held it in 5 quarters. The position peaked at $125M in Q3 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

Zeal Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Zeal Asset Management sold 194,538 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $2.06M.
Zeal Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 5 quarters.
Zeal Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $125M in Q3 2021.
75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Zeal Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.